Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study

AVB after preoperative chemotherapy is a strong, independent predictor of both EFS and OS in WT across risk groups. An AVB of ≥20 mL identifies a clinically relevant subset of patients with IRWT who may benefit from intensified therapy with doxorubicin. These findings support the use of AVB as a stratification criterion in future SIOP-RTSG protocols.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-03-13
DOI
https://doi.org/10.1200/jco-25-01755
Primary Topic
Renal and related cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study

Gema Ramirez-Villar, Filippo Spreafico, Norbert M. Graf, Harm van Tinteren et al.
Journal of Clinical Oncology
Renal and related cancers
article

Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study

Gema Ramirez-Villar, Filippo Spreafico, Norbert M. Graf, Harm van Tinteren, Nils Welter, Hervé J. Brisse, Rhoikos Furtwängler, Arnauld Verschuur, Beatriz de Camargo, Jesper Brok, Tanzina Chowdhury, Rana Dandis, C. Vokuhl, Patrick Melchior, Steven Walter Warmann, Manfred Gessler, M M van den Heuvel-Eibrink, JP Schenk, Leo Kager, Jan Godzinski, Gordan Vujanic, Aurore Coulomb-L’Hermine
article en

Abstract

AVB after preoperative chemotherapy is a strong, independent predictor of both EFS and OS in WT across risk groups. An AVB of ≥20 mL identifies a clinically relevant subset of patients with IRWT who may benefit from intensified therapy with doxorubicin. These findings support the use of AVB as a stratification criterion in future SIOP-RTSG protocols.

Journal of Clinical Oncology
University of Bonn (DE), Utrecht University (NL), Heidelberg University (DE), University Hospital Bonn (DE), Great Ormond Street Hospital (GB), University Hospital of Bern (CH), Istituto Giannina Gaslini (IT), University Hospital Heidelberg (DE), Rigshospitalet (DK), Wroclaw Medical University (PL), Sorbonne Université (FR), Hôpital Armand-Trousseau (FR), Assistance Publique Hôpitaux de Marseille (FR), Assistance Publique – Hôpitaux de Paris (FR), Comprehensive Cancer Center Mainfranken (DE), St Anna Children's Hospital (AT), Princess Máxima Center (NL), Instituto Nacional de Câncer - INCA (BR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Hospital Universitario Virgen del Rocío (ES), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Wilhelmina Children's Hospital (NL), Hôpital de la Timone (FR), University College London (GB), Charité - Universitätsmedizin Berlin (DE), Institut Curie (FR), Saarland University (DE)
Reduced inequalities
Openalex Percentile: Top 22%
Renal and related cancers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.